Ring Therapeutics IPO

Ring Therapeutics is a multi-product platform company focused on discovering and developing Anellovector therapeutics to unlock the full potential of gene therapy. Ring is aiming to pioneer the first redosable and targetable gene therapy platform by harnessing the biology of the human commensal virome. The company seeks to expand the applications of gene therapy beyond gene replacement, with the goal of enabling a much wider array of modalities and mechanisms to treat previously inaccessible diseases.

Register for Details

For more details on financing and valuation for Ring Therapeutics, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Learn more about Ring Therapeutics

Forge green plus iconForge green minus icon

Is Ring Therapeutics a publicly traded company?

Ring Therapeutics is a private company and not publicly traded.

If you are interested in buying or selling private company shares, you can register with Forge today for free to explore your options. Registering gives you access to one of our Private Market Specialists who can guide you through the process of buying or selling. Learn more about how Forge might help you buy pre-IPO shares or sell pre-IPO shares.

Forge green plus iconForge green minus icon

Will Ring Therapeutics go IPO?

Ring Therapeutics has not yet filed for an IPO. However, it's important to note that IPOs are not the sole avenue for a private company to transition to public trading. Private companies can also go public through alternative methods such as but limited to Special Purpose Acquisition Companies (SPACs), direct listings, or through mergers and acquisitions. Find out which companies are eyeing an IPO on our Tech IPO Calendar 2024.

Forge green plus iconForge green minus icon

What is Ring Therapeutics's IPO price?

The IPO price for Ring Therapeutics will be known only if it becomes public. However, you may access the "Price At Last Round" and the "Implied EV" for publicly traded comparable companies with Forge Data.
Forge green plus iconForge green minus icon

Can you invest in Ring Therapeutics pre-IPO?

Ring Therapeutics is privately held company and is not publicly traded, therefor investing in Ring Therapeutics pre-IPO is only available to accredited investors. If you meet the accreditation criteria, you can register for Forge’s Secondary Marketplace to invest in private companies before their potential IPO. If you are not an accredited investor, discover how to begin the the process to potentially qualify for new investment opportunities.

Forge green plus iconForge green minus icon

What is the value of my Ring Therapeutics shares?

To determine the value of your Ring Therapeutics shares, create a free account to gain access to Forge’s platform. Forge Markets contains pricing information for hundreds of pre-IPO companies. A Private Market Specialist will also be available to assist you with any inquiries related to your Ring Therapeutics shares. You can also learn more about how to sell your private shares before getting started.

Forge green plus iconForge green minus icon

Can you sell Ring Therapeutics before it goes public?

Yes, you can seek to sell shares in Ring Therapeutics while it remains private. If you are considering selling, you can register today for free to get started. Once registered, a Private Market Specialist will guide you through any questions you might have. You may also continue to browse through our resources to help you understand the implications and procedures involved in selling your private market shares.

Forge green plus iconForge green minus icon

What is Ring Therapeutics's funding to date?

Ring Therapeutics has raised $229.04MM to date.
Forge green plus iconForge green minus icon

When was Ring Therapeutics founded?

Ring Therapeutics was founded in 2017.

Ring Therapeutics funding rounds and last known valuation

Date Funding Round Funding Raised Price per Share Last Known Valuation

Series C

$86.5MM raised $XXX.XX $XXX.XX

Series B

$117.4MM raised $XXX.XX $XXX.XX

Series A and A-1

$25.14MM raised $XXX.XX $XXX.XX
Based on primary financings
Powered by Forge Data
Updated on: Jul 24, 2024


Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.